TipRanks
Protalix Biotherapeutics (DE:PBDA)
FRANKFURT:PBDA

Compare Protalix (PBDA) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Protalix
€2.20
€191.78M
11.24
20.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Coherus Biosciences
$1.37
$179.22M
-1.14
-30.12%
4 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$14.09
$2.29B
-55.56
586.55%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protara Therapeutics
$3.91
$163.10M
-1.99
-36.02%
3 Buy
0 Hold
0 Sell
Strong Buy
Innate Pharma
$2.27
$169.79M
-2.58
-22.35%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:PBDA
Protalix
2.37
0.35
17.08%
CHRS
Coherus Biosciences
1.16
-0.48
-29.27%
SLS
SELLAS Life Sciences Group
11.74
9.87
527.81%
TARA
Protara Therapeutics
2.70
-2.26
-45.56%
FBRX
―
―
―
―
IPHA
Innate Pharma
1.56
-0.50
-24.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts